March 30, 2022 12:16 PM EDT

EMA to clinical trial sponsors: Use your Covid-related flexibilities in responding to Ukraine crisis

Zachary Brennan

Senior Editor

Europe’s drug regulator told clinical trial sponsors that are dealing with the fallout from the war in Ukraine to use what they’ve learned from Covid …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

EMA to clinical trial sponsors: Use your Covid-related flexibilities in responding to Ukraine crisis

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Secretive Treeline Biosciences discloses $421M financing in filing

FDA approves AbbVie's 24-hour Parkinson's infusion therapy after two CRLs

House’s prominent China critic Jim McGovern leads opposition to Biosecure Act: ‘I would prefer to go back to the ...

BenevolentAI CEO is out after less than a year on the job

FDA delays colorectal cancer decision for Amgen's Lumakras, a setback in race with Bristol Myers

Join the GenScript Biotech Global Forum: Unlocking Innovations in Cell and Gene Therapies

EMA to clin­i­cal tri­al spon­sors: Use your Covid-re­lat­ed flex­i­bil­i­ties in re­spond­ing to Ukraine cri­sis

Senior Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

EMA to clinical trial sponsors: Use your Covid-related flexibilities in responding to Ukraine crisis